Compare Eli Lilly And Co (LLY) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Palantir Technologies Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Palantir Technologies Inc trades at $209.05 (market cap $477.68B). The key difference: Eli Lilly And Co is far larger — about 2.2× Palantir Technologies Inc's market cap, and Eli Lilly And Co pays a 0.59% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Palantir Technologies Inc for 78 Days on average.
| LLY | PLTR | |
|---|---|---|
Market Cap | $1.04T | $477.68B |
Volume | 3,064,878 | 41,744,992 |
Sector | Health | Technology |
52-Week High | $1.28K | $209.05 |
52-Week Low | $799.57 | $107.27 |
Typical Hold Time | 93 Days | 78 Days |
Enterprise Value | $1.09T | $468.48B |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
Palantir (PLTR) trades at $198.78, up 2.44% today, showing strong momentum with nine consecutive earnings beats. The stock exhibits bullish technical signals with current price near pivot point resistance at $199. Fundamentally, revenue grew 56.2% to $4.48B in 2025 with net income margin expanding to 36.3%, though valuation metrics remain elevated with P/E of 169.9 and P/S of 83.02. Recent partnership with Armada for sovereign AI infrastructure highlights ongoing business development.
Outlook remains positive given accelerating AI adoption and strong execution, but premium valuation and technical overbought conditions warrant caution. Key risks include growth normalization and competitive pressures. Analyst consensus is bullish with 54% buy ratings and $191.69 price target, though current price exceeds consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
